Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Powering Up In Emerging Markets Through Alliance And Pricing Strategies

This article was originally published in PharmAsia News

Executive Summary

As Merck looks to expand its geographic footprint in emerging markets, local players with extensive distribution networks will be the focus for partnerships, Merck Chief Strategy Officer and former Emerging Markets R&D Head Mervyn Turner told investors at the CLSA Emerging Markets Pharma Conference Dec.1 in New York
Advertisement

Related Content

Will World's Largest HCV Population Have Access To Newest Treatments?
Will World's Largest HCV Population Have Access To Newest Treatments?
Pfizer Looks To Team Up With Shanghai Pharmaceutical To Co-develop And Commercialize Pfizer Products In China
Pfizer Looks To Team Up With Shanghai Pharmaceutical To Co-develop And Commercialize Pfizer Products In China
Medical Device Companies Come Up With Creative Solutions To Increase Access To Rural Communities In Asia
Merck Confident With Legacy Innovation In Japan And Emerging Markets - JP Morgan Healthcare Conference
PhRMA Teams Up With Chinese Trade Group To Focus On IP Rights, Data Protection
PhRMA Teams Up With Chinese Trade Group To Focus On IP Rights, Data Protection
Merck, Cipla Deny Deal Talks But The Charm Of The Indian Market Stokes Speculations
Merck Teams Up With Sinopharm On Vaccines As It Gears Up For Gardasil Approval In China
Advertisement
UsernamePublicRestriction

Register

SC073941

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel